10x Genomics
TXG
$41.91
Share price
-7.77%
Change (1 day)
-1.16%
Change (1 year)
Categories
Revenue for 10x Genomics (TXG)
Revenue in 2023 (TTM): $0.56 B
According to 10x Genomics 's latest financial reports the company's current revenue (TTM) is $0.56 B. In 2022 the company made a revenue of $0.51 B an increase over the years 2021 revenue that were of $0.49 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for 10x Genomics from 2019 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.56 B | 10.07% |
| 2022 | $0.51 B | 5.28% |
| 2021 | $0.49 B | 64.13% |
| 2020 | $0.29 B | 21.53% |
| 2019 | $0.24 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $0.44 M | -99.92% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $5.64 M | -99.01% | 🇬🇧 UK |
 Novavax NVAX | $1.44 B | 153.41% | 🇺🇸 USA |
 Novocure
NVCR | $0.50 B | -10.69% | Jersey |